Loading clinical trials...
Loading clinical trials...
Body Surface Gastric Mapping (BSGM) to Evaluate Patients With Gastrointestinal (GI) Symptoms
Conditions
Interventions
Body surface gastric mapping device
Locations
5
United States
Alliant International University
San Diego, California, United States
Children's Mercy Hospital
Kansas City, Missouri, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Nationwide Children's Hospital
Columbus, Ohio, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Start Date
October 1, 2021
Primary Completion Date
December 31, 2027
Completion Date
June 30, 2028
Last Updated
February 10, 2026
NCT06803589
NCT05229432
NCT03876288
NCT07287943
NCT07324785
NCT03823742
Lead Sponsor
Children's Hospital of Philadelphia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions